Internal Medicine, Hematology & Oncology · Miami, FL
NPI
1952575888
Since 2008
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
8900 N Kendall Dr, Miami Cancer Institute
Miami, FL, 33176
Phone (786) 596-2000
Groups this clinician bills Medicare through
Medicare paid, 2024
$85K
1,499 services
Medicare patients, 2024
338
Average age 76
Drug cost, 2024
$5.3M
1,123 prescriptions
Company payments, 2025
$33.21
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Lisa Reale was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 454 times for 207 patients. In total Lisa Reale billed 1,499 services in 10 codes, and Medicare paid $85K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-01-30.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 454 | 207 | $13.46 | $6,111 |
| 99213 Office E&M - Established | Facility | 271 | 169 | $49.10 | $13K |
| 99233 Hospital E&M - Subsequent | Facility | 208 | 49 | $99.17 | $21K |
| 99214 Office E&M - Established | Facility | 178 | 81 | $74.50 | $13K |
| 99215 Office E&M - Established | Facility | 131 | 80 | $111.56 | $15K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 96 | 44 | $13.62 | $1,308 |
| 99214 Office E&M - Established | Office | 47 | 18 | $105.84 | $4,974 |
| 99213 Office E&M - Established | Office | 39 | 29 | $74.01 | $2,886 |
| 99215 Office E&M - Established | Office | 27 | 23 | $151.66 | $4,095 |
| 99205 Office E&M - New | Facility | 17 | 17 | $133.27 | $2,266 |
By year: 2022 $71K for 962 services; 2023 $73K for 909 services; 2024 $85K for 1,499 services.
Medicare prescription drug claims, 2024
In 2024, the drug Lisa Reale prescribed most often to Medicare patients was Acyclovir, with 98 prescriptions and refills. In total Lisa Reale wrote 1,123 Medicare prescriptions that cost $5.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Acyclovir Generic | 98 | 166 | 28 | $1,108 |
| Eliquis Apixaban | 78 | 101 | 15 | $56K |
| Imbruvica Ibrutinib | 68 | 68 | Under 11 | $833K |
| Hydroxyurea Generic | 59 | 107 | 16 | $2,106 |
| Bosulif Bosutinib | 55 | 55 | Under 11 | $836K |
| Allopurinol Generic | 49 | 77 | 25 | $217 |
| Brukinsa Zanubrutinib | 40 | 40 | Under 11 | $419K |
| Oxycodone Hcl Generic | 38 | 38 | Under 11 | $1,611 |
| Sprycel Dasatinib | 34 | 34 | Under 11 | $321K |
| Venclexta Venetoclax | 32 | 32 | Under 11 | $341K |
| Clonazepam Generic | 27 | 27 | Under 11 | $258 |
| Oxycontin Oxycodone Hcl | 26 | 26 | Under 11 | $36K |
| Jaypirca Pirtobrutinib | 25 | 25 | Under 11 | $460K |
| Tasigna Nilotinib Hcl | 25 | 25 | Under 11 | $371K |
| Temazepam Generic | 25 | 25 | Under 11 | $128 |
Brand drugs: - claims; generic drugs: 598 claims; opioid claims: 109.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Lisa Reale $33.21 ($33.21 in general payments such as food, travel and fees) from 2 companies. The largest payer was Janssen Biotech, Inc. with $17.22.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.